{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:21:39Z","timestamp":1785208899439,"version":"3.55.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Child and Adolescent Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.chc.2012.07.004","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T02:39:01Z","timestamp":1349231941000},"page":"911-939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents"],"prefix":"10.1016","volume":"21","author":[{"given":"Benjamin I.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasim S.","family":"Diler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2009.08101569","article-title":"Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) Study","volume":"166","author":"Birmaher","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jad.2011.04.036","article-title":"Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"133","author":"Dennehy","year":"2011","journal-title":"J\u00a0Affect Disord"},{"issue":"20","key":"10.1016\/j.chc.2012.07.004_bib3","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1001\/jama.293.20.2528","article-title":"The increasing medical burden in bipolar disorder","volume":"293","author":"Kupfer","year":"2005","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpeds.2006.10.070","article-title":"The poor prognosis of childhood-onset bipolar disorder","volume":"150","author":"Leverich","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.chc.2012.07.004_bib5","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jpsychires.2007.10.009","article-title":"Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder","volume":"42","author":"Soreca","year":"2008","journal-title":"J\u00a0Psychiatr Res"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-5618.2009.00686.x","article-title":"Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study","volume":"11","author":"Perlis","year":"2009","journal-title":"Bipolar Disord"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1176\/ajp.2006.163.9.1633","article-title":"Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the national epidemiologic survey on alcohol and related conditions","volume":"163","author":"Goldstein","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","article-title":"Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"55","author":"Perlis","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.chc.2008.11.003","article-title":"The concept of bipolar disorder in children: a history of the bipolar controversy","volume":"18","author":"Carlson","year":"2009","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.chc.2012.07.004_bib10","series-title":"Manic-depressive insanity and paranoia","author":"Kraepelin","year":"1921"},{"issue":"9783","key":"10.1016\/j.chc.2012.07.004_bib11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(11)60512-6","article-title":"Global burden of disease in young people aged 10-24 years: a systematic analysis","volume":"377","author":"Gore","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biopsych.2006.11.006","article-title":"Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004","volume":"62","author":"Blader","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","article-title":"National trends in the outpatient diagnosis and treatment of bipolar disorder in youth","volume":"64","author":"Moreno","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1176\/appi.ajp.160.3.430","article-title":"Defining clinical phenotypes of juvenile mania","volume":"160","author":"Leibenluft","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib15","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00004583-199507000-00010","article-title":"Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children","volume":"34","author":"Wozniak","year":"1995","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1 Pt 2","key":"10.1016\/j.chc.2012.07.004_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1399-5618.2007.00563.x","article-title":"Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis","volume":"10","author":"Youngstrom","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.chc.2012.07.004_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.10m06290","article-title":"Meta-analysis of epidemiological studies of bipolar disorder","volume":"72","author":"Van Meter","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archpedi.157.1.17","article-title":"Psychotropic practice patterns for youth: a 10-year perspective","volume":"157","author":"Zito","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaac.2010.10.006","article-title":"Service utilization for lifetime mental disorders in U.S. adolescents: results of the national comorbidity survey-adolescent supplement (NCS-A)","volume":"50","author":"Merikangas","year":"2011","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaac.2010.05.017","article-title":"Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A)","volume":"49","author":"Merikangas","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib21","first-page":"397","article-title":"Pediatric bipolar disorder versus severe mood dysregulation: risk for manic episodes on follow-up","volume":"49","author":"Stringaris","year":"2010","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archpsyc.63.2.175","article-title":"Clinical course of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Birmaher","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1399-5618.2008.00659.x","article-title":"Comparison of manic and depressive symptoms between children and adolescents with bipolar spectrum disorders","volume":"11","author":"Birmaher","year":"2009","journal-title":"Bipolar Disord"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib24","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A\u00a0prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib26","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.65.10.1125","article-title":"Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome","volume":"65","author":"Geller","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1176\/ajp.2007.164.4.582","article-title":"Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode","volume":"164","author":"DelBello","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.biopsych.2006.08.022","article-title":"Adaptive strategies for treating childhood mania","volume":"61","author":"Dawson","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.chi.0000242240.69678.c4","article-title":"Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder","volume":"46","author":"McClellan","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib30","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/ern.10.86","article-title":"Psychopharmacology of pediatric bipolar disorder","volume":"10","author":"Hamrin","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaac.2011.05.011","article-title":"Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis","volume":"50","author":"Liu","year":"2012","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pcl.2010.10.001","article-title":"Psychopharmacology of pediatric bipolar disorders in children and adolescents","volume":"58","author":"Thomas","year":"2011","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/11533110-000000000-00000","article-title":"Pharmacotherapy of bipolar disorder in children and adolescents: recent progress","volume":"24","author":"Pfeifer","year":"2010","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4088\/JCP.11m07104","article-title":"Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder","volume":"73","author":"Findling","year":"2012","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.chc.2012.07.004_bib35","unstructured":"Kowatch R, Scheffer R, Delgado S, et\u00a0al. Placebo controlled trial of valproate versus risperidone in preschool children with bipolar disorder. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Toronto, Canada. 2011."},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopsych.2005.03.019","article-title":"Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children","volume":"58","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.chc.2008.11.001","article-title":"Alternative treatments in pediatric bipolar disorder","volume":"18","author":"Potter","year":"2009","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11591660-000000000-00000","article-title":"Antidepressants and psychostimulants in pediatric populations: is there an association with mania?","volume":"13","author":"Goldsmith","year":"2011","journal-title":"Paediatr Drugs"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disord"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/chi.0b013e318040b25f","article-title":"Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials","volume":"46","author":"Correll","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.chc.2012.07.004_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.clinpsy.2.022305.095301","article-title":"Pharmacotherapy of mood disorders","volume":"4","author":"Thase","year":"2008","journal-title":"Annu Rev Clin Psychol"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib42","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/01.CHI.0000070247.24125.24","article-title":"Lithium treatment of acute mania in adolescents: a large open trial","volume":"42","author":"Kafantaris","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0165-0327(88)90023-7","article-title":"A\u00a0family study of bipolar I disorder in adolescence. Early onset of symptoms linked to increased familial loading and lithium resistance","volume":"15","author":"Strober","year":"1988","journal-title":"J\u00a0Affect Disord"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1753-2000-2-21","article-title":"The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation","volume":"2","author":"Findling","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.chc.2012.07.004_bib46","unstructured":"Kowatch R, Findling R, Scheffer R, et\u00a0al. Placebo controlled trial of divalproex versus lithium for bipolar disorder. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Boston, October 23\u201328, 2007."},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-0327(98)00175-X","article-title":"Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling","volume":"51","author":"Geller","year":"1998","journal-title":"J\u00a0Affect Disord"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archgenpsychiatry.2011.1508","article-title":"A\u00a0randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents","volume":"69","author":"Geller","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib49","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/01.chi.0000129223.89433.74","article-title":"Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study","volume":"43","author":"Kafantaris","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00004714-199504000-00006","article-title":"The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial","volume":"15","author":"Papatheodorou","year":"1995","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2005.00204.x","article-title":"Divalproex sodium for pediatric mixed mania: a 6-month prospective trial","volume":"7","author":"Pavuluri","year":"2005","journal-title":"Bipolar Disord"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib52","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00004583-200210000-00012","article-title":"An open-label trial of divalproex in children and adolescents with bipolar disorder","volume":"41","author":"Wagner","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CHI.0b013e31819c55ec","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents","volume":"48","author":"Wagner","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1755-5949.2009.00121.x","article-title":"A\u00a0prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder","volume":"16","author":"Biederman","year":"2010","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib55","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1046\/j.1440-1819.2003.01155.x","article-title":"Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review","volume":"57","author":"Davanzo","year":"2003","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004583-198701000-00002","article-title":"Carbamazepine in pediatric psychiatry","volume":"26","author":"Evans","year":"1987","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.chc.2012.07.004_bib57","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0006-3223(03)00067-2","article-title":"Combination pharmacotherapy in children and adolescents with bipolar disorder","volume":"53","author":"Kowatch","year":"2003","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004583-199903000-00022","article-title":"Case study: carbamazepine treatment of juvenile-onset bipolar disorder","volume":"38","author":"Woolston","year":"1999","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/cap.2008.0162","article-title":"A\u00a0prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder","volume":"20","author":"Joshi","year":"2010","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S1461145704004651","article-title":"A\u00a0review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder","volume":"7","author":"Hirschfeld","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/cap.2004.14.344","article-title":"Oxcarbazepine treatment of juvenile-onset bipolar disorder","volume":"14","author":"Davanzo","year":"2004","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib62","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004583-200109000-00005","article-title":"Oxcarbazepine in bipolar disorder","volume":"40","author":"Teitelbaum","year":"2001","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/104454602762599862","article-title":"Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review","volume":"12","author":"DelBello","year":"2002","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.chi.0000159151.75345.20","article-title":"A\u00a0pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder","volume":"44","author":"Delbello","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2005.15.311","article-title":"An open-label trial of risperidone in children and adolescents with bipolar disorder","volume":"15","author":"Biederman","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib67","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00004583-199908000-00011","article-title":"Risperidone treatment for juvenile bipolar disorder: a retrospective chart review","volume":"38","author":"Frazier","year":"1999","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/cap.2000.10.45","article-title":"Mood stabilizer augmentation with olanzapine in acutely manic children","volume":"10","author":"Chang","year":"2000","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0165-0327(98)00119-0","article-title":"Olanzapine in the treatment of adolescent acute mania: a report of seven cases","volume":"53","author":"Soutullo","year":"1999","journal-title":"J\u00a0Affect Disord"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib70","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A\u00a0prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib71","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1176\/appi.ajp.2007.06111932","article-title":"Olanzapine versus placebo in the treatment of adolescents with bipolar mania","volume":"164","author":"Tohen","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib72","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/cap.2004.14.405","article-title":"Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review","volume":"14","author":"Marchand","year":"2004","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.chc.2012.07.004_bib73","unstructured":"Delbello M, Findling R, Earley W, et\u00a0al. Efficacy of quetiapine in children and adolescents with bipolar mania: a 3-week double-blind, randomized, placebo-controlled trial> Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Boston, October 23\u201328, 2007."},{"key":"10.1016\/j.chc.2012.07.004_bib74","unstructured":"PDAC. Briefing document for psychopharmacologic drugs advisory committee (PDAC) meeting of June 9-10, 2009\u2013Quetiapine. Efficacy and safety of Study 149 (D1441C00149). 2009. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/PsychopharmacologicDrugsAdvisoryCommittee\/UCM170736.pdf. Accessed June 15, 2012."},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib75","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/cap.2004.14.593","article-title":"The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review","volume":"14","author":"Barzman","year":"2004","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/S1092852900019489","article-title":"Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review","volume":"10","author":"Biederman","year":"2005","journal-title":"CNS Spectr"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/YIC.0b013e3280119e0c","article-title":"Effectiveness and tolerability of aripiprazole in child and adolescent inpatients: a retrospective evaluation","volume":"22","author":"Gibson","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1017\/S1092852900021519","article-title":"An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder","volume":"12","author":"Biederman","year":"2007","journal-title":"CNS Spectr"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib79","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study","volume":"70","author":"Findling","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib80","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4088\/JCP.08m04726","article-title":"Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit\/hyperactivity disorder: a pilot randomized clinical trial","volume":"70","author":"Tramontina","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/cap.2004.14.471","article-title":"Ziprasidone monotherapy in pediatric bipolar disorder","volume":"14","author":"Barnett","year":"2004","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib82","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1399-5618.2007.00450.x","article-title":"A\u00a0prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder","volume":"9","author":"Biederman","year":"2007","journal-title":"Bipolar Disord"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib83","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/cap.2008.008","article-title":"Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder","volume":"18","author":"DelBello","year":"2008","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.chc.2012.07.004_bib84","unstructured":"Delbello M, Findling R, Wang P, et\u00a0al. Safety and efficacy of ziprasidone in pediatric bipolar disorder. Presented at the Annual Meeting of the American Psychiatric Association. Washington, DC, May 3\u20138, 2008."},{"issue":"9799","key":"10.1016\/j.chc.2012.07.004_bib85","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib86","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-5618.2010.00850.x","article-title":"Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder","volume":"12","author":"Pavuluri","year":"2010","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib87","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.chi.0000194567.63289.97","article-title":"A\u00a0double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania","volume":"45","author":"DelBello","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib88","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/104454603322724904","article-title":"Medication use in children and adolescents treated in the community for bipolar disorder","volume":"13","author":"Bhangoo","year":"2003","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib89","first-page":"231","article-title":"Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode","volume":"18","author":"Consoli","year":"2009","journal-title":"J\u00a0Can Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib90","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1089\/cap.2008.0142","article-title":"Prescribing patterns for treatment of pediatric bipolar disorder in a specialty clinic","volume":"19","author":"Potter","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib91","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A\u00a0double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib92","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1089\/cap.2006.16.336","article-title":"A\u00a0one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder","volume":"16","author":"Pavuluri","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.chc.2012.07.004_bib93","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jad.2004.05.017","article-title":"Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania","volume":"82","author":"Pavuluri","year":"2004","journal-title":"J\u00a0Affect Disord"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib94","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1089\/cap.2009.0042","article-title":"Comparison of open-label, 8-week trials of olanzapine monotherapy and topiramate augmentation of olanzapine for the treatment of pediatric bipolar disorder","volume":"19","author":"Wozniak","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib95","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/01.CHI.0000046893.27264.53","article-title":"Combination lithium and divalproex sodium in pediatric bipolarity","volume":"42","author":"Findling","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib96","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.chi.0000189135.05060.8a","article-title":"Combination lithium and divalproex sodium in pediatric bipolar symptom restabilization","volume":"45","author":"Findling","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib97","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archpsyc.61.5.459","article-title":"Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype","volume":"61","author":"Geller","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.chc.2012.07.004_bib98","series-title":"Bipolar depression: a comprehensive guide","first-page":"101","article-title":"Pediatric bipolar depression","author":"Karippot","year":"2006"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib99","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31887\/DCNS.2009.11.1\/kchang","article-title":"Challenges in the diagnosis and treatment of pediatric bipolar depression","volume":"11","author":"Chang","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"issue":"9489","key":"10.1016\/j.chc.2012.07.004_bib100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(05)67321-7","article-title":"Treatment of depression in children and adolescents","volume":"366","author":"Ryan","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib101","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archpsyc.63.8.865","article-title":"Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2003.12.011","article-title":"Treatment-emergent mania in pediatric bipolar disorder: a retrospective case review","volume":"82","author":"Faedda","year":"2004","journal-title":"J\u00a0Affect Disord"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib103","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/10445460050167296","article-title":"Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young","volume":"10","author":"Biederman","year":"2000","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib104","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10673220500326425","article-title":"Bipolar depression: issues in diagnosis and treatment","volume":"13","author":"Thase","year":"2005","journal-title":"Harv Rev Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.chc.2012.07.004_bib105","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.chc.2012.07.004_bib106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"J\u00a0Affect Disord"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib108","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disord"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib109","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00004583-200503000-00006","article-title":"Treatment guidelines for children and adolescents with bipolar disorder","volume":"44","author":"Kowatch","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.chi.0000194569.70912.a7","article-title":"Open-label lithium for the treatment of adolescents with bipolar depression","volume":"45","author":"Patel","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5414\/CPP44198","article-title":"Lamotrigine add-on therapy to venlafaxine treatment in adolescent-onset bipolar II disorder: a case report covering an 8-month observation period","volume":"44","author":"Bildik","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/cap.2006.16.357","article-title":"Adjunctive lamotrigine treatment for adolescents with bipolar disorder: retrospective report of five cases","volume":"16","author":"Soutullo","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib113","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/cap.2008.0107","article-title":"Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder","volume":"19","author":"Pavuluri","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"3","key":"10.1016\/j.chc.2012.07.004_bib114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.chi.0000194566.86160.a3","article-title":"An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression","volume":"45","author":"Chang","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2009.00728.x","article-title":"A\u00a0double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder","volume":"11","author":"DelBello","year":"2009","journal-title":"Bipolar Disord"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib116","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib117","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4088\/JCP.09r05385gre","article-title":"Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"72","author":"Sidor","year":"2011","journal-title":"The J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib118","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/07853890500284937","article-title":"The risks and benefits of antidepressant treatment for youth depression","volume":"37","author":"Bridge","year":"2005","journal-title":"Ann Med"},{"issue":"15","key":"10.1016\/j.chc.2012.07.004_bib119","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.297.15.1683","article-title":"Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment","volume":"297","author":"Bridge","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib120","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1399-5618.2005.00261.x","article-title":"Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents","volume":"7","author":"Kowatch","year":"2005","journal-title":"Bipolar Disord"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib121","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4088\/JCP.v65n0805","article-title":"Chart review of the impact of attention-deficit\/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania","volume":"65","author":"State","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib122","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-0327(98)00213-4","article-title":"Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania","volume":"51","author":"Strober","year":"1998","journal-title":"J\u00a0Affect Disord"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib123","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/070674370705200507","article-title":"Comorbidity with ADHD decreases response to pharmacotherapy in children and adolescents with acute mania: evidence from a metaanalysis","volume":"52","author":"Consoli","year":"2007","journal-title":"Can J Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.chc.2012.07.004_bib124","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.psychres.2009.01.022","article-title":"Pharmacological response in juvenile bipolar disorder subtypes: a naturalistic retrospective examination","volume":"177","author":"Masi","year":"2010","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib125","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1089\/cap.2009.0037","article-title":"Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder: a randomized crossover trial","volume":"19","author":"Zeni","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"11","key":"10.1016\/j.chc.2012.07.004_bib126","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/chi.0b013e31814b8d3b","article-title":"Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit\/hyperactivity disorder","volume":"46","author":"Findling","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib127","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1176\/appi.ajp.162.1.58","article-title":"Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium","volume":"162","author":"Scheffer","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib128","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/cap.2009.0030","article-title":"Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit\/hyperactivity disorder in children and adolescents with bipolar I or II disorder","volume":"19","author":"Chang","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib129","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1089\/cap.2005.15.996","article-title":"Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder in children and adolescents with bipolar disorders","volume":"15","author":"Hah","year":"2005","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/cap.1999.9.247","article-title":"Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder","volume":"9","author":"Biederman","year":"1999","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib131","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.63.10.1139","article-title":"Phenomenology of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Axelson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.chc.2012.07.004_bib132","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4088\/JCP.09m05845gre","article-title":"Comorbid anxiety in children and adolescents with bipolar spectrum disorders: prevalence and clinical correlates","volume":"71","author":"Sala","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.chc.2012.07.004_bib133","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/070674370104600902","article-title":"Anxiety disorders in children and adolescents with bipolar disorder: a neglected comorbidity","volume":"46","author":"Masi","year":"2001","journal-title":"Can J Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib134","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1399-5618.2010.00789.x","article-title":"Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder","volume":"12","author":"Joshi","year":"2010","journal-title":"Bipolar Disord"},{"issue":"26","key":"10.1016\/j.chc.2012.07.004_bib135","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.chc.2012.07.004_bib136","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/01.chi.0000140454.89323.99","article-title":"Risk of substance use disorders in adolescents with bipolar disorder","volume":"43","author":"Wilens","year":"2004","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib137","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1399-5618.2008.00584.x","article-title":"Substance use disorders among adolescents with bipolar spectrum disorders","volume":"10","author":"Goldstein","year":"2008","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.chc.2012.07.004_bib138","unstructured":"DelBello MP, Welge J, Adler CM, et\u00a0al. Topiramate for adolescents with co-occurring cannabis use and bipolar disorders. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Toronto (Canada), October 18\u201323, 2011."},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.159.1.13","article-title":"Treating a child with Asperger's disorder and comorbid bipolar disorder","volume":"159","author":"Frazier","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1755-5949.2010.00219.x","article-title":"Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder","volume":"18","author":"Joshi","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"8","key":"10.1016\/j.chc.2012.07.004_bib141","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1176\/ajp.2006.163.8.1451a","article-title":"Topiramate for co-occurring bipolar disorder and disruptive behavior disorders","volume":"163","author":"Barzman","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.chc.2012.07.004_bib142","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2006.16.665","article-title":"The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)","volume":"16","author":"Barzman","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib143","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/ajp.147.4.457","article-title":"Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study","volume":"147","author":"Strober","year":"1990","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib144","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/01.chi.0000155981.83865.ea","article-title":"Double-Blind 18-Month Trial of Lithium Versus Divalproex Maintenance Treatment in Pediatric Bipolar Disorder","volume":"44","author":"Findling","year":"2005","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.chc.2012.07.004_bib145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1399-5618.2010.00791.x","article-title":"Pharmacological and non-drug treatment of child bipolar I disorder during prospective eight-year follow-up","volume":"12","author":"Geller","year":"2010","journal-title":"Bipolar Disord"},{"issue":"4","key":"10.1016\/j.chc.2012.07.004_bib146","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/104454603322724913","article-title":"Long-term outcome with divalproex in children and adolescents with bipolar disorder","volume":"13","author":"Henry","year":"2003","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"issue":"1","key":"10.1016\/j.chc.2012.07.004_bib147","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/cap.2008.0106","article-title":"Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder","volume":"19","author":"Redden","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.chc.2012.07.004_bib148","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-244X-9-4","article-title":"Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine","volume":"9","author":"Duffy","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1016\/j.chc.2012.07.004_bib149","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"16","key":"10.1016\/j.chc.2012.07.004_bib150","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chc.2012.07.004_bib151","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1600-0447.2009.01454.x","article-title":"Lithium response across generations","volume":"120","author":"Grof","year":"2009","journal-title":"Acta Psychiatr Scand"}],"container-title":["Child and Adolescent Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056499312000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056499312000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T22:41:55Z","timestamp":1761000115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056499312000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":151,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1056499312000739"],"URL":"https:\/\/doi.org\/10.1016\/j.chc.2012.07.004","relation":{},"ISSN":["1056-4993"],"issn-type":[{"value":"1056-4993","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacologic Treatment of Bipolar Disorder in Children and Adolescents","name":"articletitle","label":"Article Title"},{"value":"Child and Adolescent Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chc.2012.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}